Next Article in Journal
Structural Interplays in the Flexible N-Terminus and Scaffolding Domain of Human Membrane Protein Caveolin 3
Next Article in Special Issue
Validation of Prognostic Scores in Extracorporeal Life Support: A Multi-Centric Retrospective Study
Previous Article in Journal
Modifying Cellulose Acetate Mixed-Matrix Membranes for Improved Oil–Water Separation: Comparison between Sodium and Organo-Montmorillonite as Particle Additives
Previous Article in Special Issue
Mechanical Power during Veno-Venous Extracorporeal Membrane Oxygenation Initiation: A Pilot-Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Early Findings after Implementation of Veno-Arteriovenous ECMO: A Multicenter European Experience

by
Aaron Blandino Ortiz
1,
Mirko Belliato
2,†,
Lars Mikael Broman
3,†,
Olivier Lheureux
1,
Maximilian Valentin Malfertheiner
4,†,
Angela Xini
1,
Federico Pappalardo
5,† and
Fabio Silvio Taccone
1,*
1
Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Route de Lennik, 808, B-1070 Brussels, Belgium
2
UOS Advanced Respiratory Intensive Care Unit, UOC Anestesia e Rianimazione 1, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
3
ECMO Centre Karolinska, Department of Physiology and Pharmacology, Karolinska Institutet, Karolinska University Hospital, 17177 Stockholm, Sweden
4
Department of Internal Medicine II, Cardiology and Pneumology, Intensive Care, University Medical Center Regensburg, 93053 Regensburg, Germany
5
Department of Cardiothoracic Anesthesia and Intensive Care, Advanced Heart Failure and Mechanical Circulatory Support Program, San Raffaele Hospital, Vita-Salute University, 20121 Milan, Italy
*
Author to whom correspondence should be addressed.
European ECMO Advisory Board (EEAB).
Membranes 2021, 11(2), 81; https://doi.org/10.3390/membranes11020081
Submission received: 23 December 2020 / Revised: 15 January 2021 / Accepted: 20 January 2021 / Published: 22 January 2021
(This article belongs to the Special Issue Advances in Extracorporeal Membrane Oxygenation)

Abstract

Extracorporeal membrane oxygenation (ECMO) is increasingly used to treat cardiopulmonary failure in critically ill patients. Peripheral cannulation may be complicated by a persistent low cardiac output in case of veno-venous cannulation (VV-ECMO) or by differential hypoxia (e.g., lower PaO2 in the upper than in the lower body) in case of veno-arterial cannulation (VA-ECMO) and severe impairment of pulmonary function associated with cardiac recovery. The treatment of such complications remains challenging. We report the early effects of the use of veno-arterial-venous (V-AV) ECMO in this setting. Methods: Retrospective analysis including patients from five different European ECMO centers (January 2013 to December 2016) who required V-AV ECMO. We collected demographic data as well as comorbidities and ECMO characteristics, hemodynamics, and arterial blood gas values before and immediately after (i.e., within 2 h) V-AV implementation. Results: A total of 32 patients (age 53 (interquartiles, IQRs: 31–59) years) were identified: 16 were initially supported with VA-ECMO and 16 with VV-ECMO. The median time to V-AV conversion was 2 (1–5) days. After V-AV implantation, heart rate and norepinephrine dose significantly decreased, while PaO2 and SaO2 significantly increased compared to baseline values. Lactate levels significantly decreased from 3.9 (2.3–7.1) to 2.8 (1.4–4.4) mmol/L (p = 0.048). A significant increase in the overall ECMO blood flow (from 4.5 (3.8–5.0) to 4.9 (4.3–5.9) L/min; p < 0.01) was observed, with 3.0 (2.5–3.2) L/min for the arterial and 2.8 (2.1–3.6) L/min for the venous return flows. Conclusions: In ECMO patients with differential hypoxia or persistently low cardiac output syndrome, V-AV conversion was associated with improvement in some hemodynamic and respiratory parameters. A significant increase in the overall ECMO blood flow was also observed, with similar flow distributed into the arterial and venous return cannulas.
Keywords: ECMO; veno-artero-venous; differential hypoxia; low cardiac output ECMO; veno-artero-venous; differential hypoxia; low cardiac output
Graphical Abstract

Share and Cite

MDPI and ACS Style

Blandino Ortiz, A.; Belliato, M.; Broman, L.M.; Lheureux, O.; Malfertheiner, M.V.; Xini, A.; Pappalardo, F.; Taccone, F.S. Early Findings after Implementation of Veno-Arteriovenous ECMO: A Multicenter European Experience. Membranes 2021, 11, 81. https://doi.org/10.3390/membranes11020081

AMA Style

Blandino Ortiz A, Belliato M, Broman LM, Lheureux O, Malfertheiner MV, Xini A, Pappalardo F, Taccone FS. Early Findings after Implementation of Veno-Arteriovenous ECMO: A Multicenter European Experience. Membranes. 2021; 11(2):81. https://doi.org/10.3390/membranes11020081

Chicago/Turabian Style

Blandino Ortiz, Aaron, Mirko Belliato, Lars Mikael Broman, Olivier Lheureux, Maximilian Valentin Malfertheiner, Angela Xini, Federico Pappalardo, and Fabio Silvio Taccone. 2021. "Early Findings after Implementation of Veno-Arteriovenous ECMO: A Multicenter European Experience" Membranes 11, no. 2: 81. https://doi.org/10.3390/membranes11020081

APA Style

Blandino Ortiz, A., Belliato, M., Broman, L. M., Lheureux, O., Malfertheiner, M. V., Xini, A., Pappalardo, F., & Taccone, F. S. (2021). Early Findings after Implementation of Veno-Arteriovenous ECMO: A Multicenter European Experience. Membranes, 11(2), 81. https://doi.org/10.3390/membranes11020081

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop